Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
about
Morquio A syndrome: diagnosis and current and future therapiesNew therapeutic approaches for Krabbe disease: The potential of pharmacological chaperonesScreening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compoundDietary Management of Skin Health: The Role of Genistein.Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids.Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblastsActivities of genes controlling sphingolipid metabolism in human fibroblasts treated with flavonoids.Synthetic genistein derivatives as modulators of glycosaminoglycan storage.The use of elevated doses of genistein-rich soy extract in the gene expression-targeted isoflavone therapy for Sanfilippo disease patients.Nonsteroidal anti-inflammatory drugs modulate cellular glycosaminoglycan synthesis by affecting EGFR and PI3K signaling pathwaysGene expression-targeted isoflavone therapy.Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models.Small molecules as therapeutic agents for inborn errors of metabolism.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Cyclodextrin encapsulation of daidzein and genistein by grinding: implication on the glycosaminoglycan accumulation in mucopolysaccharidosis type II and III fibroblasts.Molecular action of isoflavone genistein in the human epithelial cell line HaCaT.
P2860
Q27014063-7C4BCC1B-5F73-4F56-A1BA-26860F272899Q28068142-5648FADB-F43B-457B-9EB7-C29681DDB7ABQ28477645-7C86C514-1AE2-4F63-94C5-9E4184521716Q33852146-FBE0E446-B153-4E02-BA25-ABF79A14C446Q35206289-58408C95-9E5A-4C7E-A7E9-4C201C80536AQ35952579-FA78483A-3780-429D-B489-32BE3E2C29FFQ36030017-33EC13CD-8D7F-4C45-B5A5-DACE58077972Q36232973-573E9566-7939-4868-808F-6465CA50BEDEQ36433464-95A9C5CC-A538-440C-97C5-B659B23D031CQ37667936-42E0698B-0D5F-4C93-9C0B-126AE60259BDQ37987877-88D481E3-3DA0-4E31-B9E7-1F50C57CD6CAQ38040710-413E6624-3E0A-4927-BCD7-68F00E4A2A64Q39008165-B8425FA8-0273-4EEC-8544-F8C4176D113CQ39038060-A5E1E151-9153-4803-B7A4-6EAA53C3321AQ39060517-C062B2EC-8A90-4F63-BAE3-901231CF5C29Q49714390-41DD5077-5CCE-49EB-A30F-FF7A5727046EQ50000505-A3C48173-7750-4585-9E8C-4DEBFF6119C5
P2860
Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@ast
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@en
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@nl
type
label
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@ast
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@en
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@nl
prefLabel
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@ast
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@en
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@nl
P2860
P50
P1476
Effects of flavonoids on glyco ...... d other mucopolysaccharidoses.
@en
P2093
Anna Kloska
P2860
P2888
P356
10.1007/S11011-011-9233-2
P577
2011-02-09T00:00:00Z
P5875
P6179
1045696103